Avacta Share Discussion Threads

[tickboo] 11/2/2024 11:39

International Day of Women and Girls in ScienceTo mark 'International Day of Women and Girls in Science' day on 11 February six women scientists from Avacta share what attracted them to working in science and what they find fulfilling about their role at Avacta.Victoria Juskaite, Principal ScientistWhat attracted you to working in Science?I've always had a curious mind and really enjoyed science lessons in school. I was fascinated to learn about how things worked. Around the age of 14, I had the incredible opportunity to go on a school trip to ICL through a STEM outreach program. Spending a day with top researchers left a lasting impression on me, influencing my decision to pursue science at university and aspire to become a scientist. While completing my PhD, I realised I want to engage in more translational work that bridges scientific research with direct benefit for patients. This has brought me to the field of drug discovery in industry.What do you find fulfilling about your role at Avacta?What makes my job at Avacta so fulfilling is the team I work with and the science. We're utilising innovative technology and working on new treatments that could really help patients, which is very exciting. I like the variable nature of my work, which ranges from literature review, to advising my team on intricate scientific challenges and managing outsourced work. This keeps me engaged and constantly learning. But what I enjoy most is working together with everyone in the team. We all bring different skills to the table, and together we come up with great ideas and solutions. It feels good knowing that what we're doing could make a real difference.Melika Pajouheshpour, Placement StudentWhat attracted you to working in Science?My interest in science started when I was in secondary school. I really enjoyed learning about the molecular processes that allow our bodies to function as they do, and in particular what happens when these processes go wrong. Now, on placement at a cancer research company, I find myself continually fascinated by the intelligence of cancer cells – and how we can beat them.What do you find fulfilling about your role at Avacta?Working at Avacta has been incredibly fulfilling for me so far. Knowing that what we are working on has the potential to help patients, and that we are working with the overarching aim of a cure, is very rewarding. Science is still a male dominated field, but at Avacta I find it inspiring that there are women represented at all levels of the company, and I am very grateful to be contributing to that.Folake Orafidiya, Senior Scientist What attracted to working in scienceFrequent visit to the hospital as a child sparked my curiosity about the use and efficacy of medications as well as the mechanism behind recovery. This, alongside my interest in biology and chemistry drove my passion in understanding, contributing to and advancing science especially in the field of drug development.What do you find fulfilling about your role at AvactaA breakthrough in cancer treatment represents a glimmer of hope for patients and their loved ones. The opportunity to contribute to the research and development of innovative medicines tailored at treating patients with specific molecular profiles is profoundly rewarding. Knowing that the work I do will directly impact patient outcome – improving survival and quality of life – gives me a sense of purpose.Hanna Buist, Senior ScientistWhat attracted to working in scienceTo begin with, and it still continues to this day after almost 10 years working in Science, I was attracted to the lab work when I began my research career in academia. I've always enjoyed the planning and implementing of different experiments and I especially enjoy writing up the results, which used to be all by hand.What do you find fulfilling about your role at AvactaBesides still enjoying the lab work, even when it gets very busy, I've found it particularly fulfilling to train and work with our industrial placement students. Seeing them become capable and independent scientists at such an early stage in their careers is great as I can still remember what it was like to be in their shoes.Ellen Watts, Senior Medicinal ChemistWhat attracted you to working in Science?I always enjoyed science and maths and really connected with chemistry during my A levels. I studied Chemistry at University of Bristol and was lucky to carry out a placement year at a pharma company. I really enjoyed my time in the fast-paced, exciting environment of drug discovery and haven't stopped since! Working in drug discovery allows me to apply my interest in science to important healthcare discoveries.What do you find fulfilling about your role at Avacta?Its great to be a part of the exciting and innovative work at Avacta, exemplified by the excellent progress of our clinical candidate AVA6000. Its great to work alongside a small dynamic team and really feel like I'm are making a difference and contributing to the progress of our platforms.Marine Houee, Senior ScientistWhat attracted you to working in Science?As soon as I started studying biology in school I found it fascinating. Learning about how the human body works through genes, proteins and cells interacting at such microscopic levels was so interesting. After my baccalaureate, I did not yet know what career I wanted to pursue. I decided to focus on the subject that interested me the most and completed a BSc in Biology followed by a MSc in biotechnology. Learning more about drug research and development I realised that's how I wanted to apply my love of science, by trying to help patients live better lives.What do you find fulfilling about your role at Avacta?Being part of a team working towards the goal of transforming cancer patient outcomes, as I mentioned above, is ultimately why I work in science. In my role at Avacta, I have enjoyed working across the drug discovery pipeline, from early research discovery on our Affimer platform up to preclinical activities on our Precision programs. This has given me opportunities to work in novel areas and continue my own personal development whilst contributing to the science that will one day help improve patients' lives. I have found this to be extremely rewarding. I also appreciate how Avacta supports me in living a fulfilling life outside of work. Following my maternity leave, they have enabled me to work from home more regularly due to my long commute. This has allowed me to be able to spend more important quality time with my baby.

[amanitaangelicus] 10/2/2024 16:36

No Sandcrab. I miss out on many big rises. Why? Because I cant realistically watch many shares - you end up gambling. I have strict set up rules, entry and exit predetermined. Takes the emotion out of things. Above all, avoid a massive hit - you can then play another day. So many peeps disappear, gambling on one share. Overexposed, greed blinds them. Aim the worst mkt to play in. It.s lax, corrupt etc. Aim directors know they can get away with almost everything. Aim businesses are usually 1/2 men.s baby. It.s their retirement fund, big chance to make millions. It.s bldy dangerous. Enough from me ...at the City ground. Could easily get pasted. Mmmm...

[sandcrab2] 10/2/2024 15:07

Ama, I assume you were able to get into ARV in time, following its trading halt in Australia. Nice 80% uplift

[amanitaangelicus] 09/2/2024 17:08

Good stuff Field. Good luck with this one therefore!

[fieldhouse] 09/2/2024 16:13

Already done all that .
Avacta a few %. worth a gamble !

[amanitaangelicus] 09/2/2024 14:54

Fieldhouse ...gift it to your kids, grandkids now ...pray u live 7 yrs for max benefits. Of course you.ve got your annual gifts too. Split will trust sorted? Also steady cash out the back door helps. Just saying. Avoiding IHT isnt very bright if the Aim shares are worth peanuts.

[fieldhouse] 09/2/2024 11:37

All the main action is now focused in the US for AV6000. Fast tracking with Dr Tapp's guidance ____________!!

One of my objectives with Avacta and AIM is the inheritance tax exemption.
I don't trade because of long term objectives. A US listing would scupper that!

Each to his own

[amanitaangelicus] 09/2/2024 10:21

Fieldhouse ...full house, bingo. That good ol US listing claptrap. Zero chance. If i.d have had a pound for every Aim comment like that ...naive beyond belief.

[fieldhouse] 09/2/2024 10:16

The Cronk,

AIM is a circus, agree.
The point is the better tec's with prospects will list on the nasdaq as ARM has done.
Don't rule out Avacta with a US listing.

[amanitaangelicus] 09/2/2024 08:23

£261m mkt cap somehow. Nobody will pay £1.5B for a company at this stage in the proceedings. ie Max tol dose phase. Cheer up ,the share price is rising - must.ve read the 'undervaluation' post. Oh my sides. Ps might buy again soon ...it s bottomish again.

[amanitaangelicus] 09/2/2024 07:55

Cronk stop it ... the board gestapo will blank you. £1.5B ...I.m still rolling around the floor laughing. No news today, again. TimeLord struggling to convert interest into a deal then. Yee ha - it.s the Aim Circus

[dudishes] 08/2/2024 23:58

The Cronk, not far from the truth Sir.

[amanitaangelicus] 08/2/2024 21:10

1.5 billion ? Keep smoking that crackpipe. Hilarious. Have you not seen the mkt cap? Gee - the ramping continues unabated. Non dilutative financing ? You get nowt for free! Lose a share of profits generated which will affect shroomed pi.s. Kinderschool.

[cheshire pete] 08/2/2024 13:19

It is very quiet jacktrax. Wonder if there are discussions going on with big pharma? Guess an rns could land any time. Happy to wait for developments.

[fieldhouse] 08/2/2024 10:54

ARM up 40% on Nasdaq.

UK tec market abysmal. !

Agree jacktrax.

[jacktrax] 08/2/2024 10:22

Anyway, that's my take, could be wrong of course, I await ama to give his wisdom which I can't read as you are muted btw

[jacktrax] 08/2/2024 10:20

If you have 3 or 4 interested parties you do not want to announce to the competition at AACR. It's just to quiet imo , feels like a curve ball TO is v near. Ps. very frustrated and bored but I hold more than I have ever done, waiting ,lol

[rajraj b] 08/2/2024 09:58

Not so sure if TO is going to happen that soon as AACR is only 8 weeks away but do think a lot is going on behind the scenes especially regarding licence agreement or other non-dilutive funding arrangement. The data is slowly accruing and any interested parties will soon know what we are all sitting on here. Next 3-6 months will be immense.

[jacktrax] 08/2/2024 09:22

Well my guess is TO before AACR in April , radio silence, multiple BP interest , what price , who knows with multiple party interest , anything from 1.5 billion is my guess , yes that is low , AS has proved the science , time for BP to accelerate the platform , with multiple parties the TO price could obv be a lot higher , one day , out of the blue it will come , either you are in or out beforehand , happy Thursday all

[amanitaangelicus] 07/2/2024 14:51

Ooph close call that one Vaston. Almost got badly burnt!

[vaston] 07/2/2024 14:25

SYME IS NOW READY TO FLY

[atmysignal] 07/2/2024 14:00

Sort out the financeLet's see what it isQuickly

[amanitaangelicus] 06/2/2024 18:06

Yes Whitey ...you know what 'shipping' means now. Stick to Ladybird books.